Beam Therapeutics Inc. (BEAM) Presents at UBS Global Biopharma Conference 2026 Prepared Remarks TranscriptSeeking Alpha • Tuesday
BEAM Stock Falls 7% Despite Meeting Primary Endpoints in SCD StudyZacks Investment Research • 11/11/26
Beam Therapeutics Announces Positive Topline Pivotal Data from BEACON Phase 1/2 Trial of Risto-cel in Patients with Sickle Cell DiseaseGlobeNewsWire • 11/10/26
Beam Therapeutics to Present Updated Clinical Data from BEACON Phase 1/2 Trial of Risto-cel in Sickle Cell Disease in an Oral Presentation at American Society of Hematology (ASH) Annual MeetingGlobeNewsWire • 11/04/26
Beam Therapeutics Inc. (BEAM) Reports Q3 Loss, Misses Revenue EstimatesZacks Investment Research • 11/03/26
Beam Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Clinical Progress Across Base Editing PortfolioGlobeNewsWire • 11/03/26
Beam Therapeutics (BEAM) Moves 15.6% Higher: Will This Strength Last?Zacks Investment Research • 10/29/26
Beam Therapeutics Inc. (BEAM) Reviews Initial Phase I II BEAM-301 Data in Glycogen Storage Disease Type 1a TranscriptSeeking Alpha • 10/27/26
Beam Therapeutics Reports Initial Clinical Data from Phase 1/2 Trial of BEAM-301, Demonstrating Proof of Concept for Genetic Correction in Glycogen Storage Disease Type Ia (GSDIa) at ESGCT 33rd Annual CongressGlobeNewsWire • 10/27/26
Cathie Wood Keeps Buying Beam Therapeutics on the Dip. Should You Follow Her Lead?The Motley Fool • 10/18/26
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beam Therapeutics Inc. - BEAMPRNewsWire • 10/15/26
Beam Therapeutics to Present Initial Data from Phase 1/2 Trial of BEAM-301 in Glycogen Storage Disease Type Ia (GSDIa) at the ESGCT 33rd Annual CongressGlobeNewsWire • 10/13/26
BEAM Investors Have Opportunity to Join Beam Therapeutics Inc. Fraud Investigation with SBS LawBusiness Wire • 09/16/26
Beam Therapeutics Inc. (BEAM) Presents at Citigroup's Biopharma Back to School Summit 2026 TranscriptSeeking Alpha • 09/09/26
Beam Therapeutics Inc. (BEAM) Discusses Updated Phase 1/2 Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency TranscriptSeeking Alpha • 09/08/26